护士指南 代谢功能障碍相关的脂肪性肝病:从诊断到管理
1Department of Graduate Nursing, Jacksonville University, Jacksonville, Florida.
Journal of the American Association of Nurse Practitioners
|March 13, 2026
概括
与代谢功能障碍相关的脂肪性肝病 (MASLD) 是一个日益严重的全球健康问题. 护士从业人员的早期识别和管理对于预防严重的肝脏并发症至关重要.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 内部医学 内部医学
- 公共卫生 公共卫生
背景情况:
- 与代谢功能障碍相关的脂肪性肝病 (MASLD) 是全球最常见的慢性肝病,在30年内患病率增加了50%.
- MASLD是一种多系统性疾病,与肥胖,2型糖尿病,脂质不良和心血管疾病有关.
- MASLD的进展可能导致严重的后果,包括肝硬化,肝细胞癌和死亡.
研究的目的:
- 突出初级保健提供者的关键作用,特别是执业护士 (NP),在早期识别和管理MASLD.
- 介绍一个例证研究,说明一个患有代谢并发症和氨基转移酶升高的患者的MASLD.
- 强调有针对性的评估的重要性以及NP在MASLD的查,咨询和纵向随访中的作用.
主要方法:
- 关于MASLD流行,病理生理学和管理的当前文献的综述.
- 一个临床案例的介绍 MASLD 与代谢并发症.
- 讨论实践护士在MASLD患者护理途径中的作用.
主要成果:
- MASLD影响了全球四分之一以上的人口和近40%的美国成年人.
- 目前的管理强调改变生活方式和控制代谢并发病症.
- 有限的药理选择存在,维生素E和皮奥格利塔对特定患者有益; 新疗法正在研究中.
结论:
- 执业护士在MASLD的早期发现和管理中发挥着至关重要的作用.
- 综合管理包括生活方式的改变,并发症控制和潜在的向药物治疗.
- 针对性评估和国家医生的纵向随访对于预防疾病进展和改善患者结果至关重要.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
247
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247
01:29Chronic Pancreatitis II: Collaborative Care
456
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
456
01:25Ultrasound II: Endoscopic Ultrasound and FibroScan
983
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
983
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
309
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
309
01:24Overview of Lipid Metabolism
6.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.4K
01:30Liver Physiology
4.1K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
4.1K